Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in Romania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: Romania Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20082
20101
20131
20141
20161
20171
20181
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated3
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim2
Daiichi Sankyo2
Anthos Therapeutics, Inc.1
Atrial Fibrillation Network1
Bayer1
Bristol-Myers Squibb1
CSL Behring1
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1
Janssen Research & Development, LLC1
Janssen Scientific Affairs, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation15
Stroke4
Arrhythmias, Cardiac2
Atrial Flutter2
Embolism2
Acute Coronary Syndrome1
Atherosclerosis1
Cardiovascular Diseases1
Coronary Artery Disease1
Heart Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.